Birmingham-Based Rem3dy Health Secures €16 Million to Drive Global Expansion
Birmingham-based HealthTech scale-up, Rem3dy Health, the parent company of the personalized nutrition brand Fed, has successfully completed a €16 million (£14 million) fundraising round. This significant financial backing will support the company’s ambitious plans for growth and expansion into key international markets.
Strategic Investment from Global Leaders
The funding round was spearheaded by a consortium of global strategic investors, including household names like Suntory, Estrella Galicia, Apollo Hospitals, and UPSA. Additionally, Birmingham-based Future Planet Capital Regional’s participation underscores the company’s strong regional roots.
Rem3dy Health’s founder and CEO, Melissa Snover, remarked on the achievement, “Obtaining this funding marks a major milestone for us. After a year of significant transformation and amid some of the most challenging fundraising environments in recent years, we are now in a strong position to expand globally.”
Expanding into Global Markets and New Ventures
The funds are earmarked for expansion into crucial international markets, including the United States, MENA, and India. Furthermore, the company plans to leverage this investment to venture into personalized health solutions for pets, highlighting its innovative approach and commitment to expanding its product offerings.
This fundraising effort is part of a larger trend within the HealthTech sector. According to data, €148.2 million has been invested in HealthTech, preventive health, digital care, and patient-oriented care in 2026. The UK has been a focal point for these investments, with London-based startups like Semble, JAAQ, and Caliber securing significant funding rounds recently.
Innovative Approaches to Personalized Health
Rem3dy Health’s focus on personalized nutrition and advanced AI-driven manufacturing distinguishes it from many healthcare delivery platforms. It reflects a broader 2026 investment trend where companies utilizing data, automation, and personalization are gaining investor confidence to support scalable healthcare services.
Rupert Lyle, investment director at Future Planet Capital Regional and director of the West Midlands Co-Investment Fund (WMCO), added, “We are delighted to see Rem3dy Health continue to attract significant support to fuel its already impressive growth. When we first invested in Rem3dy, it was clear that they were developing a truly disruptive brand and technology capable of revolutionizing the global wellness industry.”
Harnessing Technology for Personalized Solutions
Founded in 2019, Rem3dy Health combines AI-driven personalized nutrition with advanced manufacturing, integrating data science, 3D printing, and automation to deliver tailored health solutions at scale. The company’s innovative use of technology positions it as a leader in the burgeoning field of personalized health.
The investment signifies a broader shift in strategy, with global consumer and healthcare players increasingly backing next-generation health technology companies. Notably, Estrella Galicia’s participation signals an expansion beyond its traditional market categories, while Apollo Hospitals brings valuable expertise as one of the world’s largest integrated healthcare providers.
For further information on Rem3dy Health’s recent fundraising and future plans, visit the source link Here.
“`
